By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Novo Nordisk A/S 

Novo Allé

Bagsvaerd    2880  Denmark
Phone: 45-4444-8888 Fax: 45-4449-0555


SEARCH JOBS


Industry
Big Pharma


Collaborations

CelTor Biosystems, Inc.  Research collaboration

Aradigm Corporation  Commercial agreement to develop AERx technology for the delivery of insulin, insulin analogues and other glucose-lowering agents for diabetes management.

Maxygen, Inc. 

Intergen Company 





Company News
Backed by Novartis AG (NVS) and Novo Nordisk A/S (NVO), UK Biotech F2G Bags $60 Million 6/20/2016 5:53:12 AM
Novo Nordisk A/S (NVO) Release: Victoza (Liraglutide) Significantly Reduced The Risk Of Major Cardiovascular Events And Death In Adults With Type 2 Diabetes In The LEADER Trial 6/14/2016 1:23:27 PM
Novo Nordisk A/S (NVO) Release: Faster-Acting Insulin Aspart Showed A Statistically Significant Reduction In Hba1c In Type 1 Diabetes And A Comparable Hba1c Reduction In Type 2 Diabetes Versus Novolog® (Insulin Aspart [rDNA Origin] Injection) 6/14/2016 11:59:02 AM
Novo Nordisk A/S (NVO) Investors Disappointed as Top Selling Drug Victoza Didn't Do as Well as Expected 6/14/2016 9:27:07 AM
Novo Nordisk A/S (NVO) Release: Semaglutide Demonstrated Superior Improvements In Glycaemic Control Vs Sitagliptin (SUSTAIN 2) And Exenatide ER (SUSTAIN 3) In Two Clinical Trials In Adults With Type 2 Diabetes 6/13/2016 12:20:11 PM
Novo Nordisk A/S (NVO) Release: Tresiba (Insulin Degludec Injection U-100) Demonstrated Significantly Lower Rates Of Overall, Nocturnal And Severe Hypoglycaemia Vs Insulin Glargine U-100 6/13/2016 11:11:18 AM
Novo Nordisk A/S (NVO) To Present 53 Abstracts At 76th Annual American Diabetes Association Scientific Sessions In New Orleans, LA 6/6/2016 12:17:07 PM
Novo Nordisk A/S (NVO) Release: Semaglutide Demonstrated Superior Glycemic Control Vs Insulin Glargine U100 In Adults With Type 2 Diabetes 5/31/2016 6:59:28 AM
FDA Panel Unanimously Backs Novo Nordisk A/S (NVO)'s Diabetes Combo Drug Ideglira 5/25/2016 5:44:54 AM
FDA Questions Study Findings, Practicality of Novo Nordisk A/S (NVO)'s Diabetes Drug Ideglira 5/23/2016 6:13:28 AM
12345678910...
//-->